| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.11 | 0.5 |